Adverse Effects of Amphotericin B in Patients of Visceral Leishmaniasis: A Short Survey at Research Hospital Patna
- 1 National Institute of Pharmaceutical Education and Research, India
- 2 National Institute of Education and Research, India
- 3 Rajendra Memorial Research Institute of Medical Sciences, India
Abstract
Leishmaniasis is a disease caused by Leishmania parasite. Leishmania currently affects 12 million people in 98 countries, with an annual incidence of approximately two million new cases. Leishmaniasis is a devastating disease impairing economic productivity and impeding socioeconomic development. The objective of this article was to study the adverse effects of amphotericin B in patients of visceral leishmaniasis which was carried out at Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India. The numbers of patients included were 19. Subjects of age groups 10-30 years (73.68%) were found to be more susceptible to visceral leishmaniasis. In this short survey we observed that the common adverse effects of amphotericin B among these patients were loss of appetite and nephrotoxicity.
DOI: https://doi.org/10.3844/ajvsp.2013.20.24
Copyright: © 2013 Surabhi Bhatnagar, Shweta, Krishna Murti, Ashok Kumar Gupta and Santosh Kumar Sudhakar. This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- 3,780 Views
- 2,827 Downloads
- 0 Citations
Download
Keywords
- Visceral Leishmaniasis
- Amphotericin B
- Adverse Effects